Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-24 Purchase |
2021-09-28 5:48 pm |
LEAP THERAPEUTICS INC. | LPTX | BeiGene Ltd. 10% Owner |
2,543,800 | $2.85 | $7,249,830 | 7,348,437 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-16 6:06 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
347,803 | $28.82 | $10,022,365 | 47,814,827 (Indirect Direct) |
View |
| 2021-08-31 Sale |
2021-09-02 8:40 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
204,358 | $24.09 | $4,922,921 | 47,814,827 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-22 Option Award |
2022-06-24 5:40 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
833,131 | $0 | 2,276,053 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:40 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
694,265 | $0 | 835,471 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
1,249,690 | $0 | 2,066,046 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
51,337 | $0 | 51,337 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
555,412 | $0 | 11,832,621 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:38 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
51,337 | $0 | 59,137 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:38 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
51,337 | $0 | 2,805,866 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:38 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
51,337 | $0 | 51,337 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:37 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
51,337 | $0 | 59,137 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:37 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
51,337 | $0 | 98,419 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:46 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
102,674 | $0 | 11,826,598 (Indirect) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:15 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
51,337 | $0 | 59,137 (Direct) |
View |
| 2022-05-17 Exercise |
2022-05-19 4:39 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
233,948 | $2.29 | 1,466,686 (Direct) |
View |
| 2022-05-17 Exercise |
2022-05-19 4:39 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
999,999 | $3.49 | 1,466,686 (Direct) |
View |
| 2022-05-17 Exercise |
2022-05-19 4:39 pm |
N/A 2026-07-13 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
1,233,947 | $0 | 1,466,686 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:12 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
61,750 | $0 | 143,299 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:10 pm |
N/A 2032-02-27 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
22,581 | $0 | 22,581 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:07 pm |
N/A 2032-02-27 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
22,581 | $0 | 22,581 (Direct) |
View |
| 2021-09-28 Gift |
2021-12-17 5:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
116,376 | $0 | 174,551 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
0 | $30.13 | 174,551 (Indirect) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
0 | $30.13 | 968,261 (Indirect) |
View |
| 2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 371,331 (Direct) |
View |
| 2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 371,331 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 6:21 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,869 | $0 | 0 (Direct) |
View |
| 2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 376,011 (Direct) |
View |
| 2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 376,011 (Direct) |
View |
| 2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 395,511 (Direct) |
View |
| 2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 395,511 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
6,000 | $119.96 | 415,011 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
78,000 | $0 | 415,011 (Direct) |
View |
| 2021-08-31 Option Award |
2021-09-02 8:39 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,374 | $0 | 0 (Direct) |
View |